Similar Search Results

Protection of traditional knowledge : deliberations from a transnational stakeholder dialogue between pharmaceutical companies and civil society organizations

Seiler, Achim; Daele, Wolfgang van den; Döbert, Rainer - 2003

Persistent link: https://www.econbiz.de/10009767686

An exploratory analysis of patent fencing in pharmaceuticals: the case of PDE5 inhibitors

Sternitzke, Christian - In: Research policy : policy, management and economic … 42 (2013) 2, pp. 542-551

Persistent link: https://www.econbiz.de/10009734242

Intellectual property management practices at small and medium-sized enterprises

Eppinger, Elisabeth; Vladova, Gergana - In: International journal of technology management : IJTM 61 (2013) 1, pp. 64-81

Persistent link: https://www.econbiz.de/10009697858

Innovating and serving the poor with antiretreviral drug systems : advances in the HIV Brazilian Program

Baracat, Maria Matilde Zraik; Nobre, Farley Simon - In: Cases on the diffusion and adoption of sustainable …, (pp. 1-19). 2013

Persistent link: https://www.econbiz.de/10009700240

Intellectual property marketplaces and how they work : evidence from German pharmaceutical firms

Andersen, Birgitte; Rossi, Federica; Stephan, Johannes - In: Intereconomics : review of European economic policy 45 (2010) 1, pp. 35-47

This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...

Persistent link: https://www.econbiz.de/10009659550